1-1 of 1
Philippe Giguere-Duval, BSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Benefits of Early Switching From Imatinib to a Second-Generation Tyrosine Kinase Inhibitor Following 12 Month Complete Cytogenetic Response Failure: A Chart Review Analysis.

Daniel J. DeAngelo, MD, PhD, Lei Chen, MD, PhD, Annie Guerin, MSc, Amy Styles, MSc, Clemence Aberki, BSc, Philippe Giguere-Duval, BSc, Eric Qiong Wu, PhD
Journal: Blood
Blood (2012) 120 (21): 2792.
https://doi.org/10.1182/blood.V120.21.2792.2792
Published: 2012